Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Proteasome inhibitor PSI induces apoptosis in human mesothelioma cells.
Sun X, Gulyás M, Hjerpe A, Dobra K. Sun X, et al. Among authors: gulyas m. Cancer Lett. 2006 Feb 8;232(2):161-9. doi: 10.1016/j.canlet.2005.02.022. Cancer Lett. 2006. PMID: 16458112
Prognostic impact of COX-2 in non-small cell lung cancer: a comprehensive compartment-specific evaluation of tumor and stromal cell expression.
Mattsson JS, Bergman B, Grinberg M, Edlund K, Marincevic M, Jirström K, Pontén F, Hengstler JG, Rahnenführer J, Karlsson MG, Karlsson C, Helenius G, Botling J, Micke P, Gulyas M. Mattsson JS, et al. Among authors: gulyas m. Cancer Lett. 2015 Jan 28;356(2 Pt B):837-45. doi: 10.1016/j.canlet.2014.10.032. Epub 2014 Oct 31. Cancer Lett. 2015. PMID: 25449785
Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium.
Gulyás M, Hjerpe A. Gulyás M, et al. J Pathol. 2003 Apr;199(4):479-87. doi: 10.1002/path.1312. J Pathol. 2003. PMID: 12635139
Species-specific in vivo engraftment of the human BL melanoma cell line results in an invasive dedifferentiated phenotype not present in xenografts.
Cedervall J, Jamil S, Prasmickaite L, Cheng Y, Eskandarpour M, Hansson J, Maelandsmo GM, Ringborg U, Gulyas M, Zhen HS, Kanter L, Ahrlund-Richter L. Cedervall J, et al. Among authors: gulyas m. Cancer Res. 2009 May 1;69(9):3746-54. doi: 10.1158/0008-5472.CAN-08-3746. Epub 2009 Apr 21. Cancer Res. 2009. PMID: 19383913
Expression of genes coding for proteoglycans and Wilms' tumour susceptibility gene 1 (WT1) by variously differentiated benign human mesothelial cells.
Gulyás M, Dobra K, Hjerpe A. Gulyás M, et al. Differentiation. 1999 Oct;65(2):89-96. doi: 10.1046/j.1432-0436.1999.6520089.x. Differentiation. 1999. PMID: 10550542
An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma.
Brockstedt U, Gulyas M, Dobra K, Dejmek A, Hjerpe A. Brockstedt U, et al. Among authors: gulyas m. Am J Clin Pathol. 2000 Aug;114(2):203-9. doi: 10.1309/QHCA-8594-TA7P-0DVQ. Am J Clin Pathol. 2000. PMID: 10941335
Mesothelial differentiation as reflected by differential gene expression.
Sun X, Gulyás M, Hjerpe A. Sun X, et al. Among authors: gulyas m. Am J Respir Cell Mol Biol. 2004 Apr;30(4):510-8. doi: 10.1165/rcmb.2003-0266OC. Epub 2003 Oct 9. Am J Respir Cell Mol Biol. 2004. PMID: 14551161
A sandwich ELISA for the estimation of human syndecan-2 and syndecan-4 in biological samples.
Seidel C, Gulyás M, David G, Dobra K, Theocharis AD, Hjerpe A. Seidel C, et al. Among authors: gulyas m. J Pharm Biomed Anal. 2004 Mar 1;34(4):797-801. doi: 10.1016/S0731-7085(03)00569-7. J Pharm Biomed Anal. 2004. PMID: 15019057
Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology.
Gulyás M, Kaposi AD, Elek G, Szollár LG, Hjerpe A. Gulyás M, et al. J Clin Pathol. 2001 Nov;54(11):831-5. doi: 10.1136/jcp.54.11.831. J Clin Pathol. 2001. PMID: 11684715 Free PMC article.
COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer.
Gulyas M, Mattsson JSM, Lindgren A, Ek L, Lamberg Lundström K, Behndig A, Holmberg E, Micke P, Bergman B; Swedish Lung Cancer Study Group. Gulyas M, et al. Acta Oncol. 2018 Feb;57(2):244-250. doi: 10.1080/0284186X.2017.1400685. Epub 2017 Nov 15. Acta Oncol. 2018. PMID: 29140138 Clinical Trial.
38 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page